![Equity Oracle: 12/20/13 teo-122013](https://themarketguys.com/wp-content/uploads/2013/12/teo-122013-120x100.png)
Cancer Genetics, Inc. (CGIX) is an early stage diagnostic company that focuses on the prognosis and response for treating cancer. There is more of a demand for companies like this than ever before and the technical charts tell us this stock is getting ready to break out. This is a contingent buy order, which means you will have to wait for the signal towards the end of the trading day before you buy it.